GOD/rGO–AuNPs/GCE |
Glucose |
1–8 mM |
10 μM |
[114] |
Graphene/nano–Au/GOD/GCE |
Glucose |
0.2–2 and 2–20 mM |
17 μM |
[124] |
Graphene/AuNPs/chitosan/GOD |
Glucose |
2–10 mM |
180 μM |
[159] |
GOD/graphene–AuNPs/GCE |
Glucose |
0.1–10 mM |
35 mM |
[160] |
Graphene Rod/AuNPs/GOD |
Glucose |
0.1–10 mM |
83 μM |
[162] |
GCE–ATP–GNs–AuNPs–GOD |
Glucose |
1–12 mM (voltammetry) |
9.3 μM |
[98] |
GCE–ATP–GNs–AuNPs–GOD |
Glucose |
1–8 mM (EIS) |
4.1 μM |
[98] |
GOD/graphene–AuNPs |
Glucose |
0.02–2.26 |
4.1 μM |
[163] |
GA@AuNPs/AuNPs |
Glucose |
0.01–16 mM |
4.0 μM |
[119] |
Graphite/SrPdO3/AuNPs |
Glucose |
0.1–6 mM |
10.1 μM |
[164] |
GOD–graphene/PANI/AuNPs/GCE |
Glucose |
0.004–1.12 mM |
0.6 μM |
[161] |
Graphene/Au–NPs/GCE |
H2O2
|
0.0005–0.5 mM |
0.44 μM |
[165] |
Nafion/Hb/AuNPs–graphene/GCE |
H2O2
|
0.0001–0.07 mM |
0.03 μM |
[87] |
GCE–GO–AuNP–ssDNA |
DNA |
- |
100 fM |
[125] |
ssDNA/AuNPs–ATPGO/GCE |
DNA |
1.0 × 10−13 to 1.0 × 10−9 M |
1.13 × 10−14 M |
[173] |
ssDNA/AuNPs/TB–GO/GCE |
MDR gene (DNA) |
1.0 × 10−11 to 1.0 × 10−9 M |
2.95 × 10−12 M |
[168] |
Capture probe (cDNA)/AuNPs–rGO/GCE |
DNA |
0.1 μM to 0.1 fM |
35 aM |
[167] |
Au film/graphene–Au nanocomposite/GCE |
Peanut allergen Ara h1 gene |
10−16 to 10−13 M |
0.041 fM |
[89] |
DHB/AuNPs/rGO/GCE |
levodopa (LD) |
0.05–1200.0 μM |
18 nM |
[90] |
Au NP/GO/GCEs |
Ascorbic Acid |
0.11–0.6 mM |
100 nM |
[81] |
Graphene/AuNPs/GCE |
DES |
1.20 × 10−8 to 1.20 × 10−5 M |
9.80 × 10−9 M |
[91] |
AuNPs/rGO/GCE |
NADH in human urine |
50 nM to 500 μM |
1.13 nM |
[41] |
AuNPs/ERGO/CILE |
Folic Acid |
0.01 μM to 50.0 μM |
2.7 nM |
[126] |
AuNPs/1-pyrene butyric acid-functionalized graphene/GCE |
Uric acid |
2.6 × 10−6 to 6.2 × 10−5 M |
2.0 × 10−7 M |
[96] |
Graphene nanosheet–PEI/AuNPs/GCE |
Dopamine |
2.0 to 48.0 μM |
0.2 μM |
[103] |
[AuNPs/rGO]20/GCE |
Dopamine |
1.0 to 60.0 μM |
0.02 μM |
[135] |
Hb/AuNPs–graphene–SDS/BPG |
Nitric oxide |
7.2 × 10−7 to 7.92 × 10−6 M |
1.2 × 10−8 M |
[94] |
Hb/AuNPs/GACS/GRE |
Nitrite |
0.05 to 1000 μM |
0.01 μM |
[172] |
AuNPs/graphene nanofibers/GCE |
Bisphenol A in baby bottle |
8.0 × 10−8 to 2.5 × 10−4 M |
3.5 × 10−8 M |
[122] |
Anti-BPA/MCH/AuNPs/graphene/GCE |
Bisphenol A in milk sample |
0.01–10.0 μM |
5 nM |
[123] |
Aflatoxin B1 antibody-AuNPs/DPB/graphene/Au electrode |
Aflatoxin B1 in spiked food |
3.2 fM–0.32 pM |
1 fM |
[121] |
AuNP/N2-doped graphene/GCE |
Chloramphenicol |
2.0 × 10−6 to 8.0 × 10−5 M |
5.9 × 10−7 M |
[112] |
Anti-estradiol antibody-AuNP–eGr/ITO |
17 β-estradiol |
1 × 10−3 to 0.1 × 10−12 M |
0.1 fM |
[120] |
rGO–AuNPs-modified GCE |
M. tuberculosis |
1.0 × 10−15 and 1.0 × 10−9 M |
fM level |
[169] |
E. coli O157:H7 antibodies-AuNPs/rGOPE |
E. coli O157:H7 |
1.5 × 102 to 1.5 × 107 cfu/mL |
1.5 × 102 cfu/mL |
[170] |
Au-graphene–AuNPs electrode |
Carbamazepine |
5 × 10−6 to 10−2 M |
3.03 × 10−6 M |
[110] |
anti-CEA/AuNPs/Arg/rGO/CILE |
CEA |
0.5 to 200 ng·mL−1
|
0.03 ng·mL−1
|
[171] |
AuNP–graphene/CILE |
Hydroquinone |
0.06 μM to 800.0 μM |
0.018 μM |
[100] |